MedTrace Logo

DISSECT-N Post Market Data Collection Registry

NCT04267055 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2025-07-03

No results posted yet for this study

Summary

DISSECT-N is a post-market registry designed to assess real-world safety and effectiveness of Valiant Navion Thoracic Stent Graft System in the treatment of thoracic aortic dissections in real world practice.

Conditions

  • Thoracic Aortic Dissection

Interventions

DEVICE

Valiant Navion Thoracic Stent Graft System

Placement of the Valiant Navion for endovascular repair of a dissection in the thoracic aorta.

Sponsors & Collaborators

  • NAMSA

    collaborator OTHER

  • Medtronic Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Ross Milner, MD · The University of Chicago Medicine & Biological Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-25
Primary Completion
2021-06-28
Completion
2024-07-05
FDA Device
Yes

Countries

  • United States
  • Denmark
  • Greece
  • Italy
  • Japan
  • Netherlands
  • New Zealand
  • Slovakia
  • South Korea
  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04267055 on ClinicalTrials.gov